High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - THORAX, 2022 - irinsubria.uninsubria.it
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - THORAX, 2023 - avesis.deu.edu.tr
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - 2023 - pubmed.ncbi.nlm.nih.gov
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - 2022 - ir.lib.uth.gr
Rationale: In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit
of high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
of high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial.
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - 2023 - cabidigitallibrary.org
Rationale: In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit
of high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
of high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - Thorax, 2022 - search.proquest.com
Methods In this multicentre, randomised, parallel-group, open-label trial, patients with
COVID-19 pneumonia and peripheral oxygen saturation (SpO 2)≤ 92% who required …
COVID-19 pneumonia and peripheral oxygen saturation (SpO 2)≤ 92% who required …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial.
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - Thorax, 2022 - europepmc.org
Methods In this multicentre, randomised, parallel-group, open-label trial, patients with
COVID-19 pneumonia and peripheral oxygen saturation (SpO 2)≤ 92% who required …
COVID-19 pneumonia and peripheral oxygen saturation (SpO 2)≤ 92% who required …
[PDF][PDF] High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - Thorax, 2022 - thorax.bmj.com
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
C Crimi, A Noto, F Madotto, M Ippolito, S Nolasco… - THORAX, 2022 - fair.unifg.it
In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of high-flow
nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO compared with …
nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO compared with …